Shows
allergytalkPediatric Hereditary Angioedema (HAE) Diagnosis & Management: Challenges, Barriers, Strategies miniseries Episode 3 – Long-Term Management and Prophylaxis for HAEHost: Kristin C. Sokol, MD, MS, MPH, FACAAI
Experts: Aleena Banerji, MD; Jonathan A. Bernstein, MD, FACAAI
Explore the strategies for long-term prophylaxis in pediatric HAE, including when to initiate treatment and the risks and benefits of various approaches. Transitioning care from childhood into adolescence and beyond is also discussed.
Learning Objective:
After listening to this podcast episode, participants should be better able to:
Employ strategies for long-term prophylaxis.
References:
Allen Meadows, MD; John Anderson, MD; Richard G. Gower, MD. Challenges in the management of...2024-12-1312 minallergytalkPediatric Hereditary Angioedema (HAE) Diagnosis & Management: Challenges, Barriers, Strategies miniseries Episode 2 – Overcoming Barriers in HAE TreatmentEpisode 2: Overcoming Barriers in HAE Treatment
Host: Kristin C. Sokol, MD, MS, MPH, FACAAI
Experts: Jonathan A. Bernstein, MD, FACAAI; Timothy J. Craig, DO, FACAAI
This episode addresses the challenges of managing HAE, including treatment differences in rural vs. urban settings, barriers to care, and the importance of shared decision-making for treatment plans. Discover effective strategies for on-demand home therapy administration.
Learning Objective:
After listening to this podcast episode, participants should be better able to:
Create effective treatment plans for their specific pop...2024-12-1320 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastLeonard B. Bacharier, MD - Episode 1: Is Your Patient’s Moderate to Severe Asthma Uncontrolled? Global Approaches to Next StepsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1314 min
PeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastArzu Yorgancioglu, MD - Episode 3: Uncontrolled Moderate to Severe Asthma in Pediatric and Adult Patients Around the World: Comparing Approaches to Treatment SelectionThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1311 minPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastKlaus F. Rabe, MD, PhD, FERS - Episode 2: Which Patients Should Receive Targeted Biologic Therapy and When?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1320 minPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastLeonard B. Bacharier, MD - Episode 1: Is Your Patient’s Moderate to Severe Asthma Uncontrolled? Global Approaches to Next StepsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1313 min
PeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastLeonard B. Bacharier, MD - Episode 4: What Are Our Most Significant Challenges in Treating Patients With Moderate to Severe Asthma and What Can We Learn From Each Other?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1318 minPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastArzu Yorgancioglu, MD - Episode 3: Uncontrolled Moderate to Severe Asthma in Pediatric and Adult Patients Around the World: Comparing Approaches to Treatment SelectionThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1311 minPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastKlaus F. Rabe, MD, PhD, FERS - Episode 2: Which Patients Should Receive Targeted Biologic Therapy and When?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1320 minPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastLeonard B. Bacharier, MD - Episode 1: Is Your Patient’s Moderate to Severe Asthma Uncontrolled? Global Approaches to Next StepsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1314 min
PeerView Clinical Pharmacology CME/CNE/CPE VideoLeonard B. Bacharier, MD - Episode 4: What Are Our Most Significant Challenges in Treating Patients With Moderate to Severe Asthma and What Can We Learn From Each Other?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1318 minPeerView Clinical Pharmacology CME/CNE/CPE VideoArzu Yorgancioglu, MD - Episode 3: Uncontrolled Moderate to Severe Asthma in Pediatric and Adult Patients Around the World: Comparing Approaches to Treatment SelectionThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1311 minPeerView Clinical Pharmacology CME/CNE/CPE VideoKlaus F. Rabe, MD, PhD, FERS - Episode 2: Which Patients Should Receive Targeted Biologic Therapy and When?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1320 minPeerView Clinical Pharmacology CME/CNE/CPE VideoLeonard B. Bacharier, MD - Episode 1: Is Your Patient’s Moderate to Severe Asthma Uncontrolled? Global Approaches to Next StepsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1313 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastLeonard B. Bacharier, MD - Episode 4: What Are Our Most Significant Challenges in Treating Patients With Moderate to Severe Asthma and What Can We Learn From Each Other?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1318 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastArzu Yorgancioglu, MD - Episode 3: Uncontrolled Moderate to Severe Asthma in Pediatric and Adult Patients Around the World: Comparing Approaches to Treatment SelectionThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1311 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastKlaus F. Rabe, MD, PhD, FERS - Episode 2: Which Patients Should Receive Targeted Biologic Therapy and When?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1320 min
PeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastLeonard B. Bacharier, MD - Episode 4: What Are Our Most Significant Challenges in Treating Patients With Moderate to Severe Asthma and What Can We Learn From Each Other?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1318 minPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastArzu Yorgancioglu, MD - Episode 3: Uncontrolled Moderate to Severe Asthma in Pediatric and Adult Patients Around the World: Comparing Approaches to Treatment SelectionThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1311 minPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastKlaus F. Rabe, MD, PhD, FERS - Episode 2: Which Patients Should Receive Targeted Biologic Therapy and When?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1320 minPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastLeonard B. Bacharier, MD - Episode 1: Is Your Patient’s Moderate to Severe Asthma Uncontrolled? Global Approaches to Next StepsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1313 min
PeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastLeonard B. Bacharier, MD - Episode 4: What Are Our Most Significant Challenges in Treating Patients With Moderate to Severe Asthma and What Can We Learn From Each Other?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1318 minPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastArzu Yorgancioglu, MD - Episode 3: Uncontrolled Moderate to Severe Asthma in Pediatric and Adult Patients Around the World: Comparing Approaches to Treatment SelectionThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1311 minPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastKlaus F. Rabe, MD, PhD, FERS - Episode 2: Which Patients Should Receive Targeted Biologic Therapy and When?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1320 minPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastLeonard B. Bacharier, MD - Episode 1: Is Your Patient’s Moderate to Severe Asthma Uncontrolled? Global Approaches to Next StepsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1314 minPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastLeonard B. Bacharier, MD - Episode 4: What Are Our Most Significant Challenges in Treating Patients With Moderate to Severe Asthma and What Can We Learn From Each Other?This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World2024-03-1318 min
PeerView Oncology & Hematology CME/CNE/CPE Video PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54PeerView Clinical Pharmacology CME/CNE/CPE VideoNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54
PeerView Internal Medicine CME/CNE/CPE Video PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54
PeerView Internal Medicine CME/CNE/CPE Audio PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54
Redpill Project - Waking Up The WorldMammography ☢️ vs Thermography , 50% Women 🤷♀️ Get False Positives, 12 Foods That Improve Gut Health 🍄Mammography ☢️ vs Thermography , 50% Women 🤷♀️ Get False Positives, 12 Foods That Improve Gut Health 🍄
Contact Me Here - ❤️ https://bit.ly/m/TammyCuthbertGarcia ❤️
Today on Naturally Inspired Radio covid was decades in the making, breast cancer screenings, mammograms vs thermography, 50% of women get a false positive, Dr Mercola, A.I., rheumatoid arthritis, gut health microbiomes, 12 foods to improve gut health, North Carolina is owned by GlaxoSmithKline
Tune In to Naturally Inspired Radio Live… Mon-Thu, 3pm (MDT) on 1360am KHNC in Colorado, at https://bit.ly/naturallyinspiredradio
Text in your comments/questions to 877-536-1360 and enter to win our we...2023-12-1451 min
Naturally Inspired Radio - Health. Freedom. News.Mammography ☢️ vs Thermography , 50% Women 🤷♀️ Get False Positives, 12 Foods For Gut Health 🍄Contact Me Here - ❤️ https://bit.ly/m/TammyCuthbertGarcia ❤️ Today on Naturally Inspired Radio covid was decades in the making, breast cancer screenings, mammograms vs thermography, 50% of women get a false positive, Dr Mercola, A.I., rheumatoid arthritis, gut health microbiomes, 12 foods to improve gut health, North Carolina is owned by GlaxoSmithKline Tune In to Naturally Inspired Radio Live… Mon-Thu, 3pm (MDT) on 1360am KHNC in Colorado, at https://bit.ly/naturallyinspiredradio Text in your comments/questions to 877-536-1360 and enter to win our weekly giveaway ...2023-12-1451 minPeerView Oncology & Hematology CME/CNE/CPE Audio PodcastBradley J. Monk, MD, FACS, FACOG - The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BVX865. CME/MOC/AAPA/IPCE credit will be available until December 10, 2024.The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial Cancer In support...2023-12-1440 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastBradley J. Monk, MD, FACS, FACOG - The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BVX865. CME/MOC/AAPA/IPCE credit will be available until December 10, 2024.The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial Cancer In support...2023-12-1440 minPeerView Clinical Pharmacology CME/CNE/CPE VideoBradley J. Monk, MD, FACS, FACOG - The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BVX865. CME/MOC/AAPA/IPCE credit will be available until December 10, 2024.The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial Cancer In support...2023-12-1440 min
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastBradley J. Monk, MD, FACS, FACOG - The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BVX865. CME/MOC/AAPA/IPCE credit will be available until December 10, 2024.The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial Cancer In support...2023-12-1440 min
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastBradley J. Monk, MD, FACS, FACOG - The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BVX865. CME/MOC/AAPA/IPCE credit will be available until December 10, 2024.The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial Cancer In support...2023-12-1440 minPeerView Oncology & Hematology CME/CNE/CPE Video PodcastBradley J. Monk, MD, FACS, FACOG - The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial CancerThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BVX865. CME/MOC/AAPA/IPCE credit will be available until December 10, 2024.The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial Cancer In support...2023-12-1440 min
AVCORPORATELTD#355 GlaxoSmithKline: A pharmaceutical and healthcare company.GlaxoSmithKline (GSK) is a multinational pharmaceutical and healthcare company headquartered in London, United Kingdom. It is one of the largest pharmaceutical companies in the world. GSK's history dates back to the 19th century, and it has a significant presence in the pharmaceutical and healthcare industries.The company is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and over-the-counter (OTC) healthcare products. GSK operates in various therapeutic areas such as respiratory, infectious diseases, oncology, vaccines, and more.https://antharas.co.uk/https://www.paypal.com/paypalme/AVCORPORATELTD?country.x=GB...2023-11-0113 min
Your Brain Uncovered with Aya TarabeineDr Mazdak Ehteramyan: Senior Scientist at GSK (GlaxoSmithKline)In this episode, my guest was Mazdak Ehteramyan, Ph.D., a senior scientist at GSK (GlaxoSmithKline). We discuss the major responsibilities inherent in the role of a senior scientist within the research and development (R&D) department. This episode covers a range of topics: a day in the life of a GSK scientist, academia vs. industry, drive vs. ambition, and the importance of cultivating people’s skills. 2023-09-1132 min
Betrifft GürtelroseGürtelrose als Gesundheitsrisiko von Arbeitnehmer*innen
Am häufigsten tritt Gürtelrose bei über 50-Jährigen auf, das inkludiert natürlich auch die arbeitende Bevölkerung in Österreich. Damit einher gehen Krankenstände und Ausfälle. Wie kann man also auch im Arbeitsumfeld auf die oft sehr schmerzhafte Erkrankung aufmerksam machen und Arbeitnehmer*innen unterstützen? Darüber spricht Moderatorin Martina Rupp mit Arbeitsmedizinerin Dr. Eva Höltl, Leiterin des Gesundheitszentrums der Erste Bank, in der achten Episode von BETRIFFT GÜRTELROSE.
Wenn Sie mit uns in Kontakt treten wollen, schreiben Sie an at.info@gsk.com. Mehr Informationen und alle Podcast-Folgen unter www.gürtelros...2023-03-0613 minBetrifft GürtelroseGürtelrose und Lungenerkrankungen – Risiko für rund eine Million Österreicher*innen
COPD-Erkrankte haben ein 10-30 % höheres Risiko an Gürtelrose zu erkranken – doch ist den Betroffenen dieses Risiko bekannt? In der siebten Folge von BETRIFFT GÜRTELROSE spricht Moderatorin Martina Rupp mit Gundula Koblmiller, Vorstandsmitglied der Österreichischen Lungenunion, darüber, warum Aufklärung von vulnerablen Personen so wichtig ist und was die österreichische Gesundheitspolitik tun kann, um den Schutz von Patient*innen mit Lungenerkrankungen zu gewährleisten.
Wenn Sie mit uns in Kontakt treten wollen, schreiben Sie an at.info@gsk.com. Mehr Informationen und alle Podcast-Folgen unter www.gürtelrose-info.at.
Für medizinischen Rat, wenden Sie sich bit...2023-03-0612 min
UK Investor MagazineNext, GlaxoSmithKline, and China with Alan GreenAlan Green joins the Podcast as we explore UK equities and key macro themes driving markets this week. We discuss:Next (LON:NXT)GlaxoSmithKline (LON:GSK)Sovereign Metals (LON:SVML)ECR Minerals (LON:ECR)We focus initially on the Chinese economy and how UK investors could play the end of the Zero COVID-19 policy, should recent rumours prove to have any weight to them.Next is a fantastic bellwether for the UK economy and to see the retailer maintain their full year profit guidance, despite co...2022-11-0231 minBetrifft GürtelroseGürtelrose und Rheuma – besonderes Risiko für Menschen mit Autoimmunerkrankung
Gürtelrose ist eine weithin unterschätzte Erkrankung und verläuft oft mit großen Schmerzen sowie teils schweren Komplikationen. Bei Menschen mit einer schweren chronischen Erkrankung kann sie aber noch stärker ausgeprägt sein. So etwa bei Rheuma-Patient*innen. Davon berichten Karin Fraunberger, Vizepräsidentin der Österreichischen Rheumaliga, und Margot Proksch, Lupus-Patientin und Gürtelrose-Betroffene in der sechsten Episode von BETRIFFT GÜRTELROSE, moderiert von Martina Rupp.
Wenn Sie mit uns in Kontakt treten wollen, schreiben Sie an at.info@gsk.com. Mehr Informationen und alle Podcast-Folgen unter www.gürtelrose-info.at.
Wenn Sie medizin...2022-09-0213 minBetrifft GürtelroseGürtelrose als „Urlaubssouvenir“ – eine Patientengeschichte
Die meisten Menschen haben von Gürtelrose schon gehört. Aber viele rechnen nicht damit, selbst zu erkranken. Und zeigt sie sich dann noch dazu in einer untypischen Weise, wird sie oftmals nicht gleich erkannt. So auch bei Alex List, der die Schmerzen im Ohr zunächst auf eine Infektion im Badeurlaub zurückführte. Er ist Fotograf, Grafikdesigner, Blogger und ehemaliger Radiomoderator bei Ö3 und erzählt seine Leidensgeschichte in der fünften Episode von BETRIFFT GÜRTELROSE seiner früheren Kollegin Martina Rupp.
Wenn Sie mit uns in Kontakt treten wollen, schreiben Sie an at.info@gsk.com. M...2022-09-0217 min
GeldmeisterinGroßbritannien - was der Aktienmarkt her gibtDer Brexit hat im Juni 2016 zumindest mein Leben verändert. Ich habe gekündigt, weil mein damaliger Arbeitgeber nicht die Bedeutung des Ereignisses erkannt hat und redaktionell nicht sofort darauf reagieren wollte. Oder habe vielleicht ich die Folgen des EU-Austritts von Großbritannien überschätzt? Das wollte ich mich beim Briten Stephen Jones, Chief Investment Officer bei Aegon Asset Management. Ich wollte von ihm wissen, was die Insulaner und den Finanzplatz London heute bewegt, wo doch am fünften September die Nachfolgerin von Boris Johnson bekanntgegeben wird. Als neue Präsidentin in Frage kommen entweder die 47-jährige Liz Tuss, di...2022-08-2843 minBetrifft GürtelroseGürtelrose als Bedrohung für immunsupprimierte Patient*innen
Gürtelrose tritt grundsätzlich am häufigsten bei Menschen über 50 auf. Patientinnen mit einem geschwächten Immunsystem haben aber altersunabhängig ein erhöhtes Risiko, an Gürtelrose zu erkranken. Was bedeutet das für diese Menschen? Haben sie „nur“ ein höheres Risiko, eine Gürtelrose zu entwickeln, oder könnte es auch zu einem schwereren Verlauf kommen? Können diese Patientinnen in gleicher Weise behandelt werden? Diese Fragen bespricht Martina Rupp in der vierte Episode von BETRIFFT GÜRTELROSE mit a.o. Univ.-Prof. Dr. Stefan Winkler, Medizinische Universität Wien.
Wenn Sie mit uns in Kontakt tret...2022-05-0214 minUK Investor MagazineLloyds, GlaxoSmithKline, and two IPOs with Alan GreenThe UK Investor Magazine Podcast is joined by Alan Green to focus on Lloyds shares, GSK and two London IPOs.Lloyds released its quarterly trading update which alluded to a slowdown in profit from Q4 2021. We discuss their dividend and what it will take for the Lloyds share price to break through 50p and back up towards 70p. With Net Income dipping from Q4 2021, there is also consideration paid to the impact of actions at the Bank of England to Lloyds shares in 2022.Despite cutting their full year dividend by 35%, GlaxoSmithKline produced a...2022-04-2733 min
Earnings SeasonGlaxoSmithKline plc, Q4 2021 Earnings Call, Feb 09, 2022GlaxoSmithKline plc, Q4 2021 Earnings Call, Feb 09, 20222022-02-091h 28UK Investor MagazineGlaxoSmithKline, UK house prices, and Sovereign Metals with Alan GreenAverage UK house prices hit a record high of £276,759 in January according to data from Halifax. This is strong backdrop for Barratt Developments who updated the market with strong forward reservations and we discuss whether this will be enough to offset fears of a slowdown in the UK housing market.GlaxoSmithKline reported a 5% increase in revenue for the last year helped by strong pharmaceutical sales. As a FTSE 100 heavy weight, we delve into the numbers and the shares outlook. Sovereign Metals is the owner of a rare rutile asset that produces Titanium for a...2022-02-0930 min
每日一經濟學人 Daily x The Economist＊第五季＊【EP. 305】#721 經濟學人導讀 feat. 國際時事 feat. 新聞評論【特殊目的收購公司：新加坡 vs. 香港；聯合利華 feat. 葛蘭素史克：錙銖必較；拜登在立法上的野心囧了；德國基督教民主聯盟 (CDU) 有請新任黨魁】❗您的一杯咖啡錢 = 我們遠大的目標！捐款支持我們：https://pse.is/3jknpx
👍Andre 老師 - 英文檢定考班，等你/妳來報名：https://reurl.cc/dGMrDV
👍Chester 老師 - 英文文法與寫作班，等你/妳來報名：https://reurl.cc/Gmaxod
👍Danny 老師 - 國際時事評論分析班，等你/妳來報名：https://reurl.cc/Q6dQ7O
👍Leon 老師 - 英文閱讀與會話班，等你/妳來報名：https://reurl.cc/Lbk1A4
🔴Friday January 21st 2022
🔵2022年1月21日星期五
🌏Espresso - The world in brief
每日濃縮 - 世界概況
1️⃣SPACs: Singapore over Hong Kong
特殊目的收購公司：「新加坡」更勝「香港」
The Singapore stock exchange debuted its first special purpose acquisition company. Vertex Technology Acquisition Corp raised S$200 million ($148 million) and is targeting sectors such as cyber security and fintech…
新加坡證券交易所首次推出其第一間特殊目的收購公司 (SPAC)。Vertex Technology Acquisition Corp (由新加坡國營的淡馬錫控股所發起) 籌集了 2億新幣 (1.48億美元)，而其目標為網絡安全以及金融科技等領域…
2️⃣Unilever feat. GlaxoSmithKline: every penny counts
聯合利華 feat. 葛蘭素史克：錙銖必較
Unilever, a household products giant, said it would not increase its latest £50bn ($68bn) bid for the consumer healthcare arm of GlaxoSmithKline. The drug company had previously turned down two other bids from Unilever, known from brands such as PG Tips tea and Dove soap…
居家 (消費性) 用品巨頭聯合利華 (Unilever) 表示不會提高對葛蘭素史克 (G...2022-01-2741 min
Die BörsenminuteGlaxoSmithKline – ein Schiff, das schwankt, nicht sinktWer meinen Podcasts BÖRSENMINUTE und GELDMEISTERIN schon länger Gehör schenkt – vielen Dank hierfür - , dem dürfte der schwer aussprechliche Name GlaxoSmithKline schon des Öfteren untergekommen sein. Denn der britische Pharmakonzern, kurz GSK, ist schon seit langem erfreulicher Bestandteil meines Wertpapiers. Und meine Freude, nicht nur wegen der Kursentwicklungen seit Jahresbeginn, sondern wegen der langfristig großzügigen Dividendenpolitik möchte ich gerne mit Euch teilen. Sie zählen seit Jahren zu den Dividengaranten, die Dividenden-Rendite ist deutlich höher als der Branchenschnitt und beträgt aktuell über fünf Prozent.
GSK ist eine Aktie, die i...2022-01-1802 minBetrifft GürtelroseGürtelrose – von brennender Bedeutung für RisikogruppenEin Podcast mit Martina Rupp
Jede/r Dritte erkrankt im Laufe seines Lebens an Gürtelrose und besonders betroffen sind Menschen, die bereits an einer Grunderkrankung leiden. Womit sind diese Menschen konfrontiert? Wieso zählen sie zu den Risikogruppen? Und wie können gerade diese Personen vorsorgen? Diese Fragen bespricht Martina Rupp in der dritten Episode von BETRIFFT GÜRTELROSE mit Mag. Jürgen E. Holzinger, Ob-mann des Vereins ChronischKrank.
Wenn Sie mit uns in Kontakt treten wollen, schreiben Sie an at.info@gsk.com. Mehr Informationen und alle Podcast-Folgen unter www.guertelrose-info.at.
Wenn Sie m...2021-12-2116 minBetrifft GürtelroseGürtelrose – oft die Ursache unbeschreiblicher SchmerzenEin Podcast mit Martina Rupp
Gürtelrose kann mit schweren und langanhaltenden Komplikationen einhergehen. Die häufigste und bekannteste ist die Post-Zoster-Neuralgie, die durch monate- oder sogar jahrelange Schmerzen charakterisiert ist und bis zu 30 % aller Patient*innen betreffen kann. Doch wie entstehen diese Schmerzen? Wie fühlen sie sich an? Und was kann man dagegen tun? Diese Fragen stellt Martina Rupp in der zweiten Episode von BETRIFFT GÜRTELROSE Dr. Waltraud Stromer, Oberärztin an der Abteilung für Anästhesie und allgemeine Intensivmedizin am Landesklinikum Waldviertel Horn und Präsidentin der Österreichischen Schmerzgesellschaft, sowie der Patientin Anna Hogl.
Wen...2021-12-2116 minBetrifft GürtelroseGürtelrose – die unterschätzte ErkrankungModeriert von Martina Rupp
Gürtelrose ist den meisten Österreicher*innen ein Begriff, die Bedeutung dieser Erkrankung wird aber weithin unterschätzt. Wie hoch ist das Risiko tatsächlich? Hat dieses Virus etwas mit dem Windpocken-Virus zu tun? Wie verläuft eine Gürtelrose üblicherweise? Und wie kann man Gürtelrose behandeln? Diese Fragen diskutiert Martina Rupp in der ersten Episode von BETRIFFT GÜRTELROSE mit Univ.-Prof. Dr. Rainer Kunstfeld, Universitätsklinik für Dermatologie, Medizinische Universität Wien.
Wenn Sie mit uns in Kontakt treten wollen, schreiben Sie an at.info@gsk.com. Mehr Informationen und alle Pod...2021-12-1914 min每日一經濟學人 Daily x The Economist＊第五季＊【EP. 277】#684 經濟學人導讀 feat. 國際時事 feat. 新聞評論【GSK 的 Sotrovimab (新冠妙方？)；羅興亞人 vs. 臉書 > 不作為也有錯；阿聯酋的週末有貓膩；充電樁遇到大瓶頸】❗您的一杯咖啡錢 = 我們遠大的目標！捐款支持我們：https://pse.is/3jknpx
👍Andre 老師 - 英文檢定考班，等你/妳來報名：https://reurl.cc/dGMrDV
👍Chester 老師 - 英文文法與寫作班，等你/妳來報名：https://reurl.cc/Gmaxod
👍Danny 老師 - 國際時事評論分析班，等你/妳來報名：https://reurl.cc/Q6dQ7O
👍Leon 老師 - 英文閱讀與會話班，等你/妳來報名：https://reurl.cc/Lbk1A4
🔴Wednesday December 8th 2021
🔵2021年12月8日星期三
🌏Espresso - The world in brief
每日濃縮 - 世界概況
1️⃣GlaxoSmithKline: our Sotrovimab brings us hope!
葛蘭素史克製藥公司：咱家 Sotrovimab 好棒棒！
GlaxoSmithKline said that its antibody treatment for covid-19 is effective against the Omicron variant. The pharmaceutical company said that Sotrovimab stood up to all the mutations of the spike protein found in the new strain of covid…
葛蘭素史克 (GlaxoSmithKline，簡稱“GSK”) 表示其針對新冠變毒的抗體治療對 Omicron 變異毒株有效。這家 (全球第九大) 製藥公司表示其 Sotrovimab 經得起新冠病毒株中發現的刺突蛋白之所有突變…
2️⃣The Rohingyas v. Facebook: a price tag on failure to act?
羅興亞人 vs. 臉書：不作為的代價？
Rohingya refugees, membe...2021-12-1432 min
Impfen – der Podcast, der unter die Haut gehtGesund älter werden – braucht man dazu Impfungen?Die Lebenserwartung in Deutschland liegt inzwischen bei rund 80 Jahren. Bei älteren Menschen ist das Immunsystem oft nicht mehr so leistungsfähig wie im jüngeren Alter. Wie Impfungen im Alter das Immunsystem „fit halten“ können, warum Grippe jedes Jahr wieder gefährlich ist und was eigentlich Immunseneszenz bedeutet, das erfahren wir im Gespräch mit Dr. Johannes Hain.
Audiofile: NP-DE-ABX-WCNT-210009, Okt21
Beschreibungstexte: NP-DE-ABX-WCNT-210008, Okt21
2021-11-0228 minImpfen – der Podcast, der unter die Haut gehtImpfen in der gynäkologischen Praxis?Auch Frauenärzte impfen - und das aus gutem Grund. Im Gespräch mit dem Gynäkologen Dr. Lutz Hoins erfahren wir, wie mit den richtigen Impfungen in der Schwangerschaft die beste Sicherheit des Kindes gewährleistet werden kann. Schon mal von der Kokonstrategie gehört? Auch Väter oder Großeltern können mithelfen, wenn es um die Sicherheit eines Babys geht. Außerdem berichtet Dr. Hoins über seine Erfahrungen im Umgang mit Impfskeptikern und warum Impfungen gegen Gürtelrose oder Gebärmutterhalskrebs essentiell sein können.
Welche Fragen haben Sie zum Thema Impfen? Teilen Sie uns mit, was...2021-10-1228 minImpfen – der Podcast, der unter die Haut gehtWie das Paul-Ehrlich-Institut für sichere Impfstoffe sorgtDie Zulassung neuer Impfstoffe ist in Deutschland Aufgabe vom Paul-Ehrlich-Institut, vom PEI. Manchmal dauert es Jahre, bis ein neuer Impfstoff auf dem Markt ist. Was viele gewundert hat: Bei Corona ging es schnell. Wie war das möglich – ohne Abstriche in Sachen Sicherheit?
Podcast: NP-DE-ABX-PCST-210006, Sep21
Text: NP-DE-ABX-WCNT-210006, Sep21
2021-09-0725 min
InfosysThe Applied AI Podcast: Sudeep Gupta on GlaxoSmithKline’s Conversational AI InitiativeWelcome to the Infosys Applied AI podcast where we converse with our clients, partners, and industry veterans in this exciting space of AI and Automation. In our first episode of this show, we meet Mr. Sudeep Gupta, Director of Data and AI Platforms at GlaxoSmithKline (GSK) Consumer Healthcare. Sudeep takes us through the Conversational AI strategy and journey at GSK and walks us through a future proof architecture of their platform.
Hosted by Abhiram Mahajani, Director of Sales for the Infosys AI and Automation Practice, UK and Europe2021-08-2317 minImpfen – der Podcast, der unter die Haut gehtDie STIKO und ihre Rolle für die ImpfempfehlungenIm Zusammenhang mit Corona Impfstoffen hat man in letzter Zeit häufiger von der STIKO gehört. Wer alles in der Ständigen Impfkommission sitzt, wie und was da entschieden wird und vieles mehr erfahren wir im Gespräch mit Dr. Bernhard Ultsch.
NP-DE-ABX-PCST-210005
2021-08-1023 minImpfen – der Podcast, der unter die Haut gehtAdjuvanzien - Zaubertränke oder Wissenschaft?In dieser Folge beleuchten Felix und Michaela das Geheimnis moderner Impfstoffe. Wo geht die Reise hin? Wie kann man sie wirksam und effektiv produzieren? Dabei spielen Adjuvanzien eine große Rolle und einer, der sich damit auskennt, ist Dr. Michael Saeftel, Senior Medical Regional Advisor bei GSK.
Audio: NP-DE-ABX-PCST-210004, Jul21
Text: NP-DE-ABX-WCNT-210005, Jul21
2021-07-0629 minImpfen – der Podcast, der unter die Haut gehtWichtige Impfungen in Zeiten von CoronaWir sprechen mit einer Allgemeinmedizinerin aus Dortmund, die viel und gerne impft. Sie erzählt uns im Interview ihre Beweggründe und klärt über die Wichtigkeit von Impfungen allgemein und speziell in Zeiten von Corona auf.
NP-DE-ABX-PCST-210003, Jun21
2021-06-1531 minImpfen – der Podcast, der unter die Haut gehtWelche Impfungen braucht mein Kind?Ein niedergelassener Kinderarzt erläutert, welche Impfungen für Säuglinge und Kleinkinder wichtig sind, wie er Eltern übers Impfen aufklärt und warum er die von der Ständigen Impfkommission empfohlenen Impfungen in seiner Praxis all seinen kleinen Patienten anbietet.
NP-DE-ABX-PCST-210002
2021-05-0628 minImpfen – der Podcast, der unter die Haut gehtBasic ImpfstinctMichaela und Felix sprechen mit Dr. Jens Vollmar, dem Leiter des medizinischen Fachbereichs Impfstoffe von GSK. Wie funktioniert das Immunsystem, was gilt es bei Impfstoffen zu beachten, wie sind sie zusammengesetzt und was ist überhaupt eine Grundimmunisierung?
2021-04-0635 minImpfen – der Podcast, der unter die Haut gehtTrailerDu wolltest schon immer wissen, warum impfen eigentlich so wichtig ist?
Oder wer bestimmt wann oder wie oft man sich impfen lassen sollte?
Dann bist du hier genau richtig!
NP-DE-MLV-PCST-210001
2021-03-1800 min
CORONAVIRUS. COVID-1965-COMPARACION Y ASPECTOS DESTACADOS DE LAS VACUNAS PARA PREVENIR EL COVID-19. ACTUALIZACIÓN A LA FECHA1 De qué país y de que laboratorio son las vacunas
*Estados unidos: Pfizer-Biontech, Moderna, Johnson & Johnson, Novavex.
*China: Sinovac-Biontech, Sonopharm
*Reino Unido: AstrasZeneca-Oxford
*Alemania: CureVac-GlaxoSmithkline
*Rusia: Gamaleya
2 Que tipo de tecnologías usan las vacunas para actuar
*mRNA: Pfizer-Biontech, Moderna, CureVac-GlaxoSmithkline
*Vector viral: Johnson & Johnson, Gamaleya
*Virus inactivado: Sinovac-Biontech, Sonopharm
*Subunidad proteica: Novavex
3 Cuantas dosis son en la aplicación de las vacunas
*Una dosis: Johnson & Johnson
*Dos dosis (cada 14 días): Sinov...2021-03-0704 min
Meet the CFOMeet the CFO #5 Tobias Hestler, GlaxoSmithKlineVom Assistenten des Divisionsleiters Tiergesundheit bis zum Global CFO des gesamten Generikageschäfts. Diese beeindruckende Karriere hat Tobias Hestler bereits mit Anfang 40 bei Novartis hingelegt. Über ein Joint Venture mit GlaxoSmithKline wechselte er schliesslich nach London und verantwortet aktuell als CFO von Consumer Healthcare eine Einheit mit mehr als 20'000 Mitarbeitenden und knapp 10 Mrd. GBP Umsatz, die bald eigenständig an die Börse geführt werden soll.In unserer neuen Folge von «Meet the CFO» erzählt Tobias Hestler, wie man sich in einem Grosskonzern über viele Karrierestufen durchsetzt, wie man sich dabei die Liebe mit dem Partn...2021-02-021h 25
No Nonsense with Pamela WallinCanadian vaccines with Paul Lucas- Former CEO of GlaxoSmithKlineCanada’s vaccine roll out is rocky. The former GlaxoSmithKline CEO Paul Lucas on why the early warning signs were missed and the importance of Canada having its own drug manufacturing capacity.Follow Pamela Wallin on Social Media:https://twitter.com/NoNonsensePWhttps://twitter.com/SenatorWallinhttps://www.facebook.com/SenPamelaWallin/Music in this podcast is used under a Creative Commons CC BY-NC3.0 Licensehttps://freemusicarchive.org/music/Chad_Crouch/Motion/Life_And_Timeshttps://www.soundofpicture.com/2021-01-2840 min
Mel's MusicThanks 4 Saving My Life! (Parody of Monsters by All Time Low, featuring Demi Lovato & blackbear)Thanks 4 Saving My Life! (Parody of Monsters by All Time Low, featuring Demi Lovato & blackbear)Original written by: Alex Gaskarth, Andrew Goldstein, Demi Lovato, Jack Barakat, Kevin Fisher, & Matthew MustoThis song is dedicated to Mepolizumab/ Nucala(the research medication that continually saves my life), to the Mayo Clinic (for caring for me for all of these years), and to my wonderful friends and family, who have traveled with me through hell and back to keep me on this planet!!! I love you all!!!!P.S. Also, thank you to gastroenterologists Dr. Kane and...2021-01-1102 min
AI Today PodcastAI Today Podcast: AI in Pharma, Interview with Subroto Mukherjee, Head of Innovation and Emerging Technology, Americas at GlaxoSmithkline Consumer HealthcareArtificial Intelligence (AI) is rapidly transforming the pharmaceutical and health care industries. No doubt with the recent global pandemic AI and machine learning is being put to use in the fight against the pandemic. In this episode of the AI Today podcast hosts Kathleen Walch and Ron Schmelzer interview Subroto Mukherjee, Head of Innovation and Emerging Technology, Americas at GlaxoSmithkline Consumer Healthcare.Continue reading AI Today Podcast: AI in Pharma, Interview with Subroto Mukherjee, Head of Innovation and Emerging Technology, Americas at GlaxoSmithkline Consumer Healthcare at Cognilytica.2020-12-1632 min
Questioning Medicine145. Rosiglitazone, Dr. Mandrola, Ethics committee, GlaxoSmithKline, and the mafiaFinance ethics committee, big pharma with deep pockets, mafia like arrangements, and a patient with a 40% increase risk of ischemia myocardial events have in common?I will say todays podcast was inspired by a tweet, yes a tweet from Dr. john Mandrola and he said “I am embarrassed to have not (really) known the details of the rosiglitazone affair. Teaching this to learners has to be 10x more valuable than the krebs cycle. My gosh – talk about lessons to learn. We have to promote more skeptical priors’ He attached a link to a paper titled2020-09-1333 min
BusinessLIVE - For Your EarWACH: Stock picks — GlaxoSmithKline and AppleGraeme Körner from Körner Perspective ( GlaxoSmithKline as his stock pick of the day and Mia Kruger from Kruger Internationals ( chose Apple.
Körner said: “I’m going for GlaxoSmithKline. I think it’s an amazing OTC [over the counter] portfolio and strong in vaccines. It also has a good pharma portfolio and I think it’s a well-run business.”
Kruger said: “I’m going to specifically focus on Apple. It’s been one of the strongest performers up to date in the US market, has a strong business.”2020-09-1100 min
Occupation StationFrom ACPHS to GlaxoSmithKlineThe path that a student embarks on is often very different from the career path they ultimately follow. ACPHS class of ’94 grad Kelly Mahar is a prime example. Kelly planned on becoming a retail pharmacist and she knew that there were lots of attractive jobs open in the field. But during her coursework and internships at ACPHS, Kelly started to notice her strengths and interests lay elsewhere. In this episode of Occupation Station hear how Kelly was able to put her degree from ACPHS into lucrative service to support her new goal to earn a Ph.D. from the University of...2020-08-0715 min
Win More PodcastGlaxoSmithKline & Warner Music GroupGlaxoSmithKline Consumer Health taps a new agency of record for digital and social after naming an interim Chief Marketing Officer. https://edge.winmo.com/hubnews/articles/31022
Also, Warner Music Group names Eric Wong as their new President and Chief Marketing Officer. https://edge.winmo.com/hubnews/articles/310242020-07-1321 minWin More PodcastGlaxoSmithKline & The GrommetGlaxoSmithKline promotes from within to find an interim Chief Marketing Officer as they launch a new ad campaign and begin testing a coronavirus vaccine. https://edge.winmo.com/hubnews/articles/30943
Also, The Grommet promotes their Chief Marketing Officer to President through a time of low spending. https://edge.winmo.com/hubnews/articles/309492020-07-0116 min
Investec IndiaPharma Expert Series: GlaxoSmithKline PLCConfinement, social distancing, lockdown... the world is trying every measure to slow down the pandemic which caused with more than 2,00,000 deaths and over 3 million cases globally. However eventually the only way to actually prevent people from catching Covid-19 is with a vaccine. Nearly 80 companies and academic institutions are racing to produce one. GlaxoSmithKline a leading vaccine manufacturer recently collaborated with Sanofi to develop a COVID Vaccine.
Anshuman Gupta, Pharma Analyst, Investec India spoke with James Dodwell, Director, Investor Relations & Danielle Smith, Director, Investor Relations to get insights into the Vaccine development and potential, new businesses and market opportunities.2020-05-0751 min
CVC Unplugged06 April 2020 – Lyell Immunopharma Gains $493m Investment from GlaxoSmithKlineThe Big Ones It is the sort of line to awaken the curiosity in an annual report: “Cash payments to acquire equity investments amounted to £258m…
The post 06 April 2020 – Lyell Immunopharma Gains $493m Investment from GlaxoSmithKline appeared first on CVC Unplugged.2020-04-0624 min
Global Venturing Review06 April 2020 – Lyell Immunopharma Gains $493m Investment from GlaxoSmithKlineThe Big Ones
It is the sort of line to awaken the curiosity in an annual report: “Cash payments to acquire equity investments amounted to £258m [$314m] (2018 – £309m), primarily relating to Lyell Immunopharma.”
Thus, the accountants revealed UK-listed drugs maker GlaxoSmithKline (GSK) had invested a sizeable amount in US-based cancer treatment developer Lyell Immunopharma, which raised $493m earlier this month.
Late last week, US-listed software provider Microsoft fell into the latter camp as it agreed with AnyVision that “it is in the best interest of both enterprises for Microsoft to divest its shareholding in AnyVision”.2020-04-0624 min
The Healthtech PodcastEpisode 32: The Story of GlaxoSmithKline and the Importance of Design In Healthtech 🧬James is joined by Andrew Barraclough, VP of design and innovation at GlaxoSmithKline. With thirty years’ experience, Andrew Barraclough is a leading voice at the heart of design and innovation in the healthcare and FMCG sectors. Andrew joined GlaxoSmithKline in 2011, having previously worked Design Business Association, Novartis Consumer Health, Reckitt Benckiser and Pure Realisation, which he founded. As Vice President of design and innovation at GSK, Andrew has continued to push the boundaries of perception of design across 146+ markets for 25+ global brands, including Panadol, Sensodyne, Theraflu and Flonase. Andrew’s mission at GSK is to embed world class design-thinking and cu...2019-07-1853 min
The Water CoolestFed raises rates, Altria invests in Juul & Pfizer and GlaxoSmithKline to join forcesIn today’s Minutes: Fed raises rates and markets plummet, Altria invests in Juul, and drug maker’s Pfizer and GlaxoSmithKline partner up
---
Support this podcast: https://anchor.fm/watercoolesthq/support2018-12-2002 minThe Water CoolestShell ties exec pay to carbon footprint, GlaxoSmithKline buys Tesaro & Qatar drops out of OPECIn today’s Minutes: Shell will tie its executives pay to the company’s carbon footprint going forward, GlaxoSmithKline buys Tesaro for $5.1B, and Qatar announces it is leaving OPEC. Plus, get your Bill Gates on.
---
Support this podcast: https://anchor.fm/watercoolesthq/support2018-12-0402 min
Daily Business HeadstartMattel Announces Layoffs, GlaxoSmithKline Teams up with 23andMe, and ClassPass Lands $85 Million in New FundingHere’s your Headstart on the business headlines you need to know for Thursday, July 26th, 2018. Coming up: Mattel Announces Layoffs, GlaxoSmithKline Teams up with 23andMe, Waymo Teams up with Walmart, and ClassPass Lands $85 Million in New Funding. We’ll have these stories and more in under 3-minutes. See acast.com/privacy for privacy and opt-out information.2018-07-2600 min
Investors' ChronicleBull vs Bear: GlaxoSmithKlineGlaxoSmithKline (GSK) is a company that divides opinion and therefore an ideal candidate for the IC's Bull vs Bear series. In this episode, Simon Gergel from the Merchants Trust argues the bull case against the ICs pharma specialist (and GSK sceptic), Megan Boxall. Hosted on Acast. See acast.com/privacy for more information.2018-05-1618 min
Neurology® PodcastJanuary 9 2018 Issue1) Featured Article: Quality improvement in neurology: Child neurology quality measure set2) Lesson of the Week: Update on chronic migraine risk factors, management, and treatmentThis Neurology® Podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the January 9, 2018, issue of Neurology. In the first segment, Dr. Adam Numis talks with Dr. Jeffrey Buchhalter and Dr. Anup Patel about their quality measure set executive summary article regarding child neurology. For the “Lesson of the Week” segment, Dr. Tesha Monteith speaks with Dr. Stephen Silberstein about chronic migraine.DISCLOSURES:Dr. Numis serves on the editorial team for the Neurology® Reside...2018-01-0825 minNeurology® PodcastSeptember 12 2017 IssueShow description/summary:1) National randomized controlled trial of virtual house calls for Parkinson disease2) Neurology Today: Interview with Joseph Safdieh, the new Editor-in-Chief of Neurology Today®This podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the September 12, 2017 issue of Neurology. In the first segment, Dr. Jeff Ratliff talks with Dr. Ray Dorsey about his paper on virtual house calls for Parkinson disease. In the second part of the podcast, Dr. Andy Southerland interviews Dr. Joseph Safdieh about Dr. Safdieh’s new position as Editor in Chief of Neurology Today. Disclosures can be found at Neu...2017-09-1118 min
ChapmanCG Global HR InterviewsGlaxoSmithKline, Yi Wang - China's Productivity Challenge (Ben Davies)According to the Oxford Economics, China’s labour costs are only 4% cheaper than that of the US’s. And because China no longer enjoys its once cheap labour and capital, it must now switch focus to productivity as more and more MNCs rely on China for profit.
But what can HR leaders do to affect productivity in their organization? And what tools do they have at their disposal if they can? Ben Davies speaks with Yi Wang, Vice President & Area HR Director at GlaxoSmithKline, about China’s challenges in developing productivity and how HR leaders can lead the charge.
Divider by Chr...2017-07-2708 min
SOAR (SCN) PodcastEP38 - Deborah MyersJoin our community to receive notifications, event updates, and more:http://soarcommunitynetwork.comDeborah has more than 25 years of professional experience in international economic development, including advocacy, public policy and developing strategic partnerships. She worked with major corporations, governments, non-government organizations, and international organizations to find solutions for issues facing the developing world.In 2009 Deborah founded VirtuArte to help people become more intentional gift givers by assisting them to select the perfect gift for their gift-giving occasion. The gifts are selected from a curated collection of handcrafted works of art by artisans from developing countries. The sales help artisans from around...2017-06-1437 minNeurology® PodcastDecember 13 2016 Issue1) AAN guideline summary: Treatment of restless legs syndrome in adults 2) What's Trending: Interview with Dr. Steven Messé on why acute ischemic stroke patients are not receiving IV tPA3) Topic of the month: Neurology Today story about cases of acute flaccid myelitis spike: What the Center for Disease Control says you should look out forThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Fullard interviews Dr. John Winkelman about the AAN guideline summary on the treatment of restless legs syndrome i...2016-12-1335 minNeurology® PodcastNovember 1 2016 Issue1) School aged cognition in children exposed to levetiracetam, topiramate or sodium valproate2) What's Trending: Interview with David Spencer about his book titled: “Navigating life with epilepsy” 3) Topic of the month: How to examine and approach movement disordersThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Nathan Fountain interviews Dr. Rebecca Bromley about her paper about school aged cognition in children exposed to levetiracetam, topiramate or sodium valproate. Dr. Ted Burns is interviewing Dr. David Spencer for our “What's Trending” feature of the w...2016-10-3128 minNeurology® PodcastOctober 11 2016 Issue1) Reducing costs while enhancing quality of care in MS2) What's Trending: Interview with Lyell Jones about the topic of the Axon Registry and how it interfaces with practice and reimbursement this is part 2 with part 1 appearing last month 3) Topic of the month: Neurology Today story on the AAN Guideline published in Neurology on the topic of recurrent stroke with patent foramen ovaleThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interviews Dr. Ilya Kister about his paper on...2016-10-1128 min
ChapmanCG Global HR InterviewsGlaxoSmithKline, Magnus Hibbert - Developing World-Class HR Operations (Matt Chapman)World-class HR organisations deliver high quality strategic workforce planning and employee analytics while at the same time operating at a lower cost per employee than their peer organisations.
The key to this success can be attributed to a well-designed and executed service delivery model (SDM) that emphasises operational excellence. Magnus Hibbert, Global Head of Shared Services at GlaxoSmithKline, discusses developing World-Class HR Operations.2016-03-2218 minNeurology® PodcastJuly 30 2013 Issue1) Evidence-based guideline: Treatment of tardive syndromes and 2) Topic of the month: AAN Plenary Sessions. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Waugh interviews Drs. Roongroj Bhidayasiri and Gary Gronseth about the AAN evidence-based guideline on treatment of tardive syndromes. Dr. Roy Strowd is reading our e-Pearl of the week about CTA spot sign. In the next part of the podcast Dr. Alberto Espay interviews Dr. Marsel Mesulam about his H. Houston Merritt Lecture on the selective cognitive...2013-07-3024 minNeurology® PodcastMay 28 2013 Issue1) Evidence-based guideline on periprocedural management of antithrombotic medications and neurovascular disease and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Melissa Armstrong about the guideline on periprocedural management of antithrombotic medications and neurovascular disease. Dr. Roy Strowd is reading our e-Pearl of the week about HINTS of stroke. In the next part of the podcast Dr. Binit Shah interviews Dr. Kapil Sethi about management of of non-dopa...2013-05-2820 minNeurology® PodcastJanuary 15 2013 Issue1) Incident Parkinson disease and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Dr. Tien Khoo about his paper on incident Parkinson disease. Dr. Jen Fugate is reading our e-Pearl of the week about paroxysmal dysarthria and ataxia. In the next part of the podcast Dr. Mike Sowell interviews Dr. Alan Finkel about the topic of post-traumatic headache. The participants had nothing to disclose except Drs. Morgan, Khoo, Fugate and Finkel.Dr...2013-01-1522 min
Medizin - Open Access LMU - Teil 19/22Effects of different chlorhexidine pretreatments on adhesion of metal brackets in vitroObjective: To investigate the effect of chlorhexidine applications in various forms and concentrations on adhesion and failure modes of metal brackets in vitro. Material and methods: Ninety bovine enamel specimens were allocated to six groups (n=15). Metal brackets were bonded on all specimens after chlorhexidine pre-treatments forming the following groups: (1) untreated specimens (control); (2) 40% varnish (EC40, Biodent BV, Netherlands), remnants removed with brushing mimicking patient cleaning; (3) 40% varnish (EC40), remnants removed with brushing mimicking professional cleaning; (4) 1% varnish (Cervitec Plus, Ivoclar vivadent, Schaan, Liechtenstein), remnants not removed; (5) brushed with% 1 gel (Corsodyl, GlaxoSmithKline, Munchenbuchsee, Germany), remnants not removed; (6) immersed in 0.07% mouthrinse (Corsodyl, GlaxoSmithKline, Munchenbuchsee...2012-01-0100 min
PharmaVOICE PodcastsStandards for Industry-Sponsored Studies and Journal Publication Planning<div><div><b>Date Posted:</b> 03/12/2010<br /><b>Size:</b> 6.53MB<br /><b>Length:</b> 00:14:16<br /><b>Thought Leaders:</b> Bernadette Mansi, Scientific Communications Strategy Head, Cardiovascular, Metabolism and Ophthalmology, GlaxoSmithKline, and Dr. Trish Groves, Deputy Editor, British Medical Journal</div><div><br /></div><div>In this episode we cover the Medical Publishing Insights and Practices...2010-04-0850 min